Back to mobile site

Stifel Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)

September 14, 2026 11:05 AM EDT Send to a Friend
Stifel analyst Alex Thompson reiterated a Buy rating and $28.00 price target on Cullinan Oncology Inc. (NASDAQ: CGEM).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login